HHMI - Howard Hughes Medical Institute

HHMI scientists have joined their colleagues around the world in working to understand and slow the spread of COVID-19. They’re developing diagnostic testing, understanding the virus’s basic biology, modeling the epidemiology, and developing potential therapies or vaccines.

The Trustees of the Howard Hughes Medical Institute (HHMI) have elected Donald Koch as chief investment officer and a vice president of HHMI.

A new study is currently enrolling people with long COVID who have not yet been vaccinated. The work could tell researchers what’s driving the condition and offer clues to treatment. 

Sugars attach to certain RNA molecules on the outside membrane of the cell. The newly discovered “glycoRNAs” may be involved in immune signaling.

Researchers have, for the first time, decoded the neural signals associated with writing letters, then displayed typed versions of these letters in real time. They hope their invention could one day help people with paralysis communicate.

A bold project to read the complete genetic sequences of every known vertebrate species reaches its first milestone by publishing new methods and the first 25 high-quality genomes.

An ion channel called TRPC5 acts as a molecular cold sensor in teeth and could serve as a new drug target for treating toothaches.

Intensive training in young mice staves off symptoms of a rare neurological disorder that afflicts young girls. The discovery may spark new ideas for treatments in humans.

Scientists have identified proteins in aphid saliva that can alter plant development. These proteins drive abnormal growths called galls, which give insects a protected place to feed and reproduce.